SCIENCE CHINA
Life Sciences
REVIEW
April 2013 Vol.56 No.4: 298–305
doi: 10.1007/s11427-013-4466-4
Advance in herpes simplex viruses for cancer therapy
LIU ShangLong, DAI MeiHua, YOU Lei & ZHAO YuPei*
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &
Peking Union Medical College, Beijing 100730, China
Received November 12, 2012; accepted February 27, 2013
Oncolytic virotherapy is an attractive approach that uses live viruses to selectively kill cancer cells. Oncolytic viruses can be genetically engineered to induce cell lyses through virus replication and cytotoxic protein expression. Herpes simplex virus (HSV) has become one of the most widely clinically used oncolytic agent. Various types of HSV have been studied in basic or clinical research. Combining oncolytic virotherapy with chemotherapy or radiotherapy generally produces synergic action with unclear molecular mechanisms. Arming HSV with therapeutic transgenes is a promising strategy and can be used to comple-ment conventional therapies. As an efficient gene delivery system, HSV has been successfully used to deliver various immuno- modulatory molecules. Arming HSV with therapeutic genes merits further investigation for potential clinical application. oncolytic viruses, herpesvirus, virotherapy, cancer, gene therapy
Citation: Liu S L, Dai M H, You L, et al. Advance in herpes simplex viruses for cancer therapy. Sci China Life Sci, 2013, 56: 298–305, doi: 10.1007/s11427-
013-4466-4
Cancer cells are still difficult to destroy at present. Five- protein expression and activation of host immune system [2]. year survival rates for pancreatic, liver and lung cancer re-As the mechanisms are different from chemotherapies and
main disappointing. It is reported that 15 million new cancer radiotherapies, oncolytic virotherapies often synergize with cases and 10 million new deaths are expected in 2020 [1]. these traditional approaches [3]. Various different viruses Carcinogenesis is a multi-step process involving various are undergoing preclinical or clinical research, including mutation points in genome. A single treatment is insuffi-vaccinia, adenovirus, herpes simplex virus, reovirus and
cient and various therapeutic strategies are needed due to Newcastle disease [4]. Herpes simplex virus (HSV) is one the cancer heterogeneity. Surgery, chemotherapy and radio- of the most widely clinically used oncolytic agent. As the therapy are three major approaches to treat cancer at present. first oncolytic viruses to be introduced in fighting against However, chemotherapy and radiotherapy often have lim-cancer, HSV are easily manipulated and can be inserted
ited effects with toxicities. Oncolytic virotherapy is based transgene. Moreover, previous work from our studies and on the concept of using live viruses to selectively replicate others has shown that HSV combined with radiotherapies or in cancer cells, with minimal toxicity to normal tissue. It is chemotherapies produce synergistic action [5,6]. The HSV a novel way to eradicate cancer cells. Oncolytic viruses can used as oncolytic agents offer some advantages: (i) HSV be genetically engineered to specially target cancer cells and infects most tumor cells types and replicates rapidly in in-induce cell lyses. The mechanisms of oncolytic viruses de-fected cells; (ii) HSV virions have the ability of viral pene-stroying cancer cells are still unclear. They may be associ-tration within tumor; (iii) HSV with a large genome is easily ated with virus replication in cancer cells, virus cytotoxic manipulated and can be inserted multiple transgenes; (iv)
HSV replication can be shut off with anti-HSV drug if re-
quired [7–10]. In this review, we will focus on the anti-
*Corresponding author (email: zhaoyp8028@gmail.com)
© The Author(s) 2013. This article is published with open access at Springerlink.com life.scichina.com doc.guandang.net
小议中医药在治疗肿瘤中的特色和优势_专业资料。随着现代生活压力的增大,环境污染加重,肿瘤疾病已成了危害人们健康与生命的最大杀手之一;面对西医治疗时过度攻伐...
浅谈中医膏方在恶性肿瘤的治疗优势_中医中药_医药卫生_专业资料 暂无评价
HSV1-tk基因在肿瘤报告基因显像与治疗中的研究进展_专业资料。自杀基因疗法是一种有潜在临床应用价值的肿瘤治疗策略。HSV1-tk基因兼具治疗基因和报告基因的功能,可...
泌尿系统肿瘤HSV—TK基因治疗的研究进展_IT/计算机_专业资料。维普资讯 http://www.cqvip.com 重庆 医学 20牟 2月第302 1卷第 2期 1 41 emfihs ...
单一方案治疗肿瘤时代已结束,将各种肿瘤方法的 优势有机地结合起来,综合治疗已成为肿瘤治疗的方 向。 晚期肿瘤的主要治疗手段:放疗、化疗。辅助手段: 生物治疗、...
中医药治疗恶性肿瘤的特色和优势_专业资料。随着人类平均寿命的延长,生活方式的改变,环境污染的加剧,诊断水平的提高等原因,恶性肿瘤的发病率和死亡率近年来逐年增加...
但针灸 治疗肿瘤的临床研究还存在些许缺点,今后可以在临床实践中进行探 索,更好更广泛地发挥针灸治疗肿瘤的优势和作用。 郑照君 2014-01-28 ...
本文重点介绍聚合物胶束在肿瘤治疗中 的优势。 1 聚合物胶束的潜在优势 Gros 等 [ 2] 首次将聚合物胶束应用于肿瘤治疗 中。常见的聚合物胶束是两亲性嵌段...
1.1.1.5 单纯疱疹病毒(HSV) HSV-1 是嗜神经性病毒,该载体可用于脑肿瘤基因治疗。其优点是容量大(40~45kb) ,能 感染有丝分裂后细胞,能永久维持潜伏状态等...
5.中西医结合是当今治疗恶性肿瘤最具有优势与特色的疗法之一。 6.肿瘤治疗存在...8.单纯疱疹病毒-2(HSV-2)和人乳头状瘤病毒(HPV)——宫颈癌 EB 病毒——...
热门文档